Search

Your search keyword '"Darifenacin -- Product development"' showing total 1 results
Start Over Descriptor "Darifenacin -- Product development" Journal m2 presswire

Refine your results

1 results on '"Darifenacin -- Product development"'

1. Overactive Bladder Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies by DelveInsight | Bayer, Taiho Pharmaceutical, Astellas Pharma Inc, Kyorin Pharmaceutical, Novartis

Subjects
Astellas Pharma Inc. -- Product development, Bayer AG -- Product development, Pfizer Inc. -- Product development, Novartis AG -- Product development, Business -- Research, Medical research, Medicine, Experimental, Mirabegron, Drugs -- Product development, Clinical trials, Darifenacin -- Product development, Pharmaceutical industry -- Product development, Business, Business, international
Abstract

M2 PRESSWIRE-June 6, 2023-: Overactive Bladder Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies by DelveInsight | Bayer, Taiho Pharmaceutical, Astellas Pharma Inc, Kyorin Pharmaceutical, Novartis (C)1994-2023 M2 [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results